<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34638645</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10305</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910305</ELocationID><Abstract><AbstractText>Leptin has been suggested to play a role in amyotrophic lateral sclerosis (ALS), a fatal progressive neurodegenerative disease. This adipokine has previously been shown to be associated with a lower risk of ALS and to confer a survival advantage in ALS patients. However, the role of leptin in the progression of ALS is unknown. Indeed, our understanding of the mechanisms underlying leptin's effects in the pathogenesis of ALS is very limited, and it is fundamental to determine whether alterations in leptin's actions take place in this neurodegenerative disease. To characterize the association between leptin signaling and the clinical course of ALS, we assessed the mRNA and protein expression profiles of leptin, the long-form of the leptin receptor (Ob-Rb), and leptin-related signaling pathways at two different stages of the disease (onset and end-stage) in TDP-43<sup>A315T</sup> mice compared to age-matched WT littermates. In addition, at selected time-points, an immunoassay analysis was conducted to characterize plasma levels of total ghrelin, the adipokines resistin and leptin, and metabolic proteins (plasminogen activator inhibitor type 1 (PAI-1), gastric inhibitory peptide (GIP), glucagon-like peptide 1 (GLP-1), insulin and glucagon) in TDP-43<sup>A315T</sup> mice compared to WT controls. Our results indicate alterations in leptin signaling in the spinal cord and the hypothalamus on the backdrop of TDP-43-induced deficits in mice, providing new evidence about the pathways that could link leptin signaling to ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferrer-Donato</LastName><ForeName>Agueda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Unit of the National Hospital of Paraplegics (UDI-HNP), Finca La Peraleda s/n, 45007 Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2185-0851</Identifier><AffiliationInfo><Affiliation>Health Research Centre (CEINSA), University of Almeria (UAL), Carr. Sacramento, s/n, 04120 Almeria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frago</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-5927-9240</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Ni&#xf1;o Jes&#xfa;s, Instituto de Investigaci&#xf3;n la Princesa, Universidad Aut&#xf3;noma de Madrid, 28009 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Fisiopatolog&#xed;a de la Obesidad y la Nutrici&#xf3;n (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowen</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-4770-2291</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Ni&#xf1;o Jes&#xfa;s, Instituto de Investigaci&#xf3;n la Princesa, Universidad Aut&#xf3;noma de Madrid, 28009 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Fisiopatolog&#xed;a de la Obesidad y la Nutrici&#xf3;n (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMDEA Food Institute, CEI UAM + CSIC, 28048 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Martos</LastName><ForeName>Carmen M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-6387-4456</Identifier><AffiliationInfo><Affiliation>Research Unit of the National Hospital of Paraplegics (UDI-HNP), Finca La Peraleda s/n, 45007 Toledo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart 7001, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BFU2017-82565-C2-1-R</GrantID><Agency>Ministry of Education, Science and Innovation</Agency><Country/></Grant><Grant><GrantID>SBPLY/17/180501/000303</GrantID><Agency>Junta de Comunidades de Castilla-La Mancha</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054392">Adipokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D054392" MajorTopicYN="N">Adipokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAR DNA binding protein (TDP-43)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">leptin</Keyword><Keyword MajorTopicYN="N">long leptin receptor (Ob-Rb)</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34638645</ArticleId><ArticleId IdType="pmc">PMC8508891</ArticleId><ArticleId IdType="doi">10.3390/ijms221910305</ArticleId><ArticleId IdType="pii">ijms221910305</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tapia R. Cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: A perspective. Front. Cell Neurosci. 2014;8:241. doi: 10.3389/fncel.2014.00241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00241</ArticleId><ArticleId IdType="pmc">PMC4132292</ArticleId><ArticleId IdType="pubmed">25177274</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens T.W., Basinski M.B., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L.S., Hale E.J., Hoffmann J., Hsiung H.M., Kriauciunas A., et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530&#x2013;532. doi: 10.1038/377530a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/377530a0</ArticleId><ArticleId IdType="pubmed">7566151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425&#x2013;432. doi: 10.1038/372425a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/372425a0</ArticleId><ArticleId IdType="pubmed">7984236</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763&#x2013;770. doi: 10.1038/27376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/27376</ArticleId><ArticleId IdType="pubmed">9796811</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Martos C.M., Gonzalez P., Rodriguez F.J. Acute leptin treatment enhances functional recovery after spinal cord injury. PLoS ONE. 2012;7:e35594. doi: 10.1371/journal.pone.0035594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035594</ArticleId><ArticleId IdType="pmc">PMC3334982</ArticleId><ArticleId IdType="pubmed">22536415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wang S., Signore A.P., Chen J. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke. 2007;38:2329&#x2013;2336. doi: 10.1161/STROKEAHA.107.482786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.482786</ArticleId><ArticleId IdType="pubmed">17600230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fewlass D.C., Noboa K., Pi-Sunyer F.X., Johnston J.M., Yan S.D., Tezapsidis N. Obesity-related leptin regulates Alzheimer&#x2019;s Abeta. FASEB J. 2004;18:1870&#x2013;1878. doi: 10.1096/fj.04-2572com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-2572com</ArticleId><ArticleId IdType="pubmed">15576490</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco S.J., Sarkar S., Casadesus G., Zhu X., Smith M.A., Ashford J.W., Johnston J.M., Tezapsidis N. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci. Lett. 2009;455:191&#x2013;194. doi: 10.1016/j.neulet.2009.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.03.066</ArticleId><ArticleId IdType="pmc">PMC2681253</ArticleId><ArticleId IdType="pubmed">19429119</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco S.J., Sarkar S., Johnston J.M., Tezapsidis N. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem. Biophys. Res. Commun. 2009;380:98&#x2013;104. doi: 10.1016/j.bbrc.2009.01.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.01.041</ArticleId><ArticleId IdType="pmc">PMC2657956</ArticleId><ArticleId IdType="pubmed">19166821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M.A., Bence K.K., Sandesara I., Andreux P., Auwerx J., Ishibashi J., Seale P., Kalb R.G. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:4995&#x2013;5008. doi: 10.1093/hmg/ddu214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu214</ArticleId><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., Steyn F.J., Huang L., Mantovani S., Pfluger C.M., Woodruff T.M., O&#x2019;Sullivan J.D., Henderson R.D., McCombe P.A. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2015;357:22&#x2013;27. doi: 10.1016/j.jns.2015.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G., Peter R.S., Rosenbohm A., Koenig W., Dupuis L., Rothenbacher D., Ludolph A.C. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis&#x2014;Results from a population- based ALS registry in Germany. Sci. Rep. 2017;7:4374. doi: 10.1038/s41598-017-04706-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04706-5</ArticleId><ArticleId IdType="pmc">PMC5491500</ArticleId><ArticleId IdType="pubmed">28663573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Phan K., Highton-Williamson E., Strikwerda-Brown C., Caga J., Ramsey E., Zoing M., Devenney E., Kim W.S., Hodges J.R., et al. Eating peptides: Biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Ann. Clin. Transl. Neurol. 2019;6:486&#x2013;495. doi: 10.1002/acn3.721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.721</ArticleId><ArticleId IdType="pmc">PMC6414477</ArticleId><ArticleId IdType="pubmed">30911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin A.S., Lee V.M., Trojanowski J.Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010;6:211&#x2013;220. doi: 10.1038/nrneurol.2010.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.18</ArticleId><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Morozova N., Weisskopf M.G., McCullough M.L., Munger K.L., Calle E.E., Thun M.J., Ascherio A. Diet and amyotrophic lateral sclerosis. Epidemiology. 2008;19:324&#x2013;337. doi: 10.1097/EDE.0b013e3181632c5d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181632c5d</ArticleId><ArticleId IdType="pubmed">18300717</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K., Kihira T., Kondo T., Kobashi G., Washio M., Sasaki S., Yokoyama T., Miyake Y., Sakamoto N., Inaba Y., et al. Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph. Lateral Scler. 2007;8:300&#x2013;304. doi: 10.1080/17482960701472249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701472249</ArticleId><ArticleId IdType="pubmed">17852010</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink J.H., Kalmijn S., Groeneveld G.J., Wunderink W., Koster A., de Vries J.H., van der Luyt J., Wokke J.H., Van den Berg L.H. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2007;78:367&#x2013;371. doi: 10.1136/jnnp.2005.083378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083378</ArticleId><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Cutler R.G., Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 2007;9:17&#x2013;20. doi: 10.1385/NMM:9:1:17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:9:1:17</ArticleId><ArticleId IdType="pubmed">17114821</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J.L., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Varghese M., Vempati P., Dzhun A., Cheng A., Wang J., Lange D., Bilski A., Faravelli I., Pasinetti G.M. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7:e49191. doi: 10.1371/journal.pone.0049191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049191</ArticleId><ArticleId IdType="pmc">PMC3492315</ArticleId><ArticleId IdType="pubmed">23145119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., Humala N., Thiyagarajan M., Wang J., Pasinetti G.M. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29. doi: 10.1186/1471-2202-7-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-7-29</ArticleId><ArticleId IdType="pmc">PMC1488864</ArticleId><ArticleId IdType="pubmed">16584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T., Bogdanik L.P., Tassinari V.R., Kidd J.D., Moreno A.J., Davis C., Osborne M., Austin A., Vieira F.G., Lutz C., et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59&#x2013;72. doi: 10.1016/j.brainres.2013.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A., Ferrer-Donato A., Cabrera-Pinto M., Sese&#xf1;a S., Fern&#xe1;ndez P., Aranda A., Fernandez-Martos C.M. Effect of ozone exposure on Amyotrophic Lateral Sclerosis (ALS) pathology using a mice model of TDP-43 proteinopathy. bioRxiv. 2021 doi: 10.1101/2021.02.12.430915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.12.430915</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez C.M., Molto E., Gallardo N., del Arco A., Martinez C., Andres A., Ros M., Carrascosa J.M., Arribas C. The expression of rat resistin isoforms is differentially regulated in visceral adipose tissues: Effects of aging and food restriction. Metabolism. 2009;58:204&#x2013;211. doi: 10.1016/j.metabol.2008.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2008.09.014</ArticleId><ArticleId IdType="pubmed">19154953</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega Moreno L., Sanz-Garcia A., Fernandez de la Fuente M.J., Arroyo Solera R., Fernandez-Tome S., Marin A.C., Mora-Gutierrez I., Fernandez P., Baldan-Martin M., Chaparro M., et al. Serum adipokines as non-invasive biomarkers in Crohn&#x2019;s disease. Sci. Rep. 2020;10:18027. doi: 10.1038/s41598-020-74999-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74999-6</ArticleId><ArticleId IdType="pmc">PMC7582883</ArticleId><ArticleId IdType="pubmed">33093517</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Deng J., Jaffa M., Cudkowicz M.E., Wills A.M. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili M.A., Panahi M., Yadav S., Hennings L., Kiaei M. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int. J. Exp. Pathol. 2013;94:56&#x2013;64. doi: 10.1111/iep.12006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iep.12006</ArticleId><ArticleId IdType="pmc">PMC3575874</ArticleId><ArticleId IdType="pubmed">23317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang Q., Zhang K., An T., Shi P., Li Z., Duan W., Li C. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 2012;1460:88&#x2013;95. doi: 10.1016/j.brainres.2012.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.04.003</ArticleId><ArticleId IdType="pubmed">22578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina D.X., Orr M.E., Oddo S. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice. Neurobiol. Aging. 2014;35:79&#x2013;87. doi: 10.1016/j.neurobiolaging.2013.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.07.006</ArticleId><ArticleId IdType="pubmed">23954172</ArticleId></ArticleIdList></Reference><Reference><Citation>Munzberg H., Singh P., Heymsfield S.B., Yu S., Morrison C.D. Recent advances in understanding the role of leptin in energy homeostasis. F1000Research. 2020;9 doi: 10.12688/f1000research.24260.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.24260.1</ArticleId><ArticleId IdType="pmc">PMC7255681</ArticleId><ArticleId IdType="pubmed">32518627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Rui L. Leptin signaling and leptin resistance. Front. Med. 2013;7:207&#x2013;222. doi: 10.1007/s11684-013-0263-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-013-0263-5</ArticleId><ArticleId IdType="pmc">PMC4069066</ArticleId><ArticleId IdType="pubmed">23580174</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front. Neurosci. 2016;10:611. doi: 10.3389/fnins.2016.00611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target? Cell Biosci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy metabolism in ALS: An underappreciated opportunity? Acta. Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Lanznaster D., Veyrat-Durebex C., Hergesheimer R., Vourch P., Maillot F., Andres C.R., Pradat P.F., Corcia P. Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis. Expert Rev. Neurother. 2020;20:907&#x2013;919. doi: 10.1080/14737175.2020.1788389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1788389</ArticleId><ArticleId IdType="pubmed">32583696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Chiang P.M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. USA. 2010;107:16325&#x2013;16330. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejanin A., Tammewar G., Marx G., Cobigo Y., Iaccarino L., Kornak J., Staffaroni A.M., Dickerson B.C., Boeve B.F., Knopman D.S., et al. Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology. 2020;95:e140&#x2013;e154. doi: 10.1212/WNL.0000000000009760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009760</ArticleId><ArticleId IdType="pmc">PMC7455324</ArticleId><ArticleId IdType="pubmed">32591470</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chua S., Jr. Leptin Function and Regulation. Compr. Physiol. 2017;8:351&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">29357132</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S., Danzaki K., MacIver N.J. Nutritional effects on T-cell immunometabolism. Eur. J. Immunol. 2017;47:225&#x2013;235. doi: 10.1002/eji.201646423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646423</ArticleId><ArticleId IdType="pmc">PMC5342627</ArticleId><ArticleId IdType="pubmed">28054344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gomez J.J., Ballesteros-Pomar M.D., Torres-Torres B., De la Maza B.P., Penacho-Lazaro M.A., Palacio-Mures J.M., Abreu-Padin C., Lopez-Guzman A., De Luis-Roman D.A. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria. Clin. Nutr. 2021;40:237&#x2013;244. doi: 10.1016/j.clnu.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.014</ArticleId><ArticleId IdType="pubmed">32507583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Dorst J., Dreyhaupt J., Weishaupt J.H., Kassubek J., Weiland U., Meyer T., Petri S., Hermann A., Emmer A., et al. Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm T., Maier A., Wicks P., Lang D., Linke P., Munch C., Steinfurth L., Meyer R., Meyer T. Severe loss of appetite in amyotrophic lateral sclerosis patients: Online self-assessment study. Interact. J. Med. Res. 2013;2:e8. doi: 10.2196/ijmr.2463.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/ijmr.2463</ArticleId><ArticleId IdType="pmc">PMC3632382</ArticleId><ArticleId IdType="pubmed">23608722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Coccurello R. What is &#x201c;Hyper&#x201d; in the ALS Hypermetabolism? Mediat. Inflamm. 2017;2017:7821672. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pundir C.S., Narwal V. Biosensing methods for determination of triglycerides: A review. Biosens. Bioelectron. 2018;100:214&#x2013;227. doi: 10.1016/j.bios.2017.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2017.09.008</ArticleId><ArticleId IdType="pubmed">28918230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379:632&#x2013;635. doi: 10.1038/379632a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/379632a0</ArticleId><ArticleId IdType="pubmed">8628397</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263&#x2013;1271. doi: 10.1016/0092-8674(95)90151-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90151-5</ArticleId><ArticleId IdType="pubmed">8548812</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela L., Horvath T.L. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 2012;13:1079&#x2013;1086. doi: 10.1038/embor.2012.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2012.174</ArticleId><ArticleId IdType="pmc">PMC3512417</ArticleId><ArticleId IdType="pubmed">23146889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang P.M., Ling J., Jeong Y.H., Price D.L., Aja S.M., Wong P.C. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl. Acad. Sci. USA. 2010;107:16320&#x2013;16324. doi: 10.1073/pnas.1002176107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002176107</ArticleId><ArticleId IdType="pmc">PMC2941284</ArticleId><ArticleId IdType="pubmed">20660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T., Yamasaki R., Takeuchi H., Kadomatsu K., Kira J.I., Jinno S. Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2017;46:2001&#x2013;2014. doi: 10.1111/ejn.13650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13650</ArticleId><ArticleId IdType="pubmed">28715117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T., Yamasaki R., Kira J.I., Jinno S. Upregulation of Vesicular Glutamate Transporter 2 and STAT3 Activation in the Spinal Cord of Mice Receiving 3,3&#x2019;-Iminodipropionitrile. Neurotox. Res. 2018;33:768&#x2013;780. doi: 10.1007/s12640-017-9822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9822-x</ArticleId><ArticleId IdType="pubmed">28965218</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron A., Dungan Lemko H.M., Castorena C.M., Fujikawa T., Lee S., Lord C.C., Ahmed N., Lee C.E., Holland W.L., Liu C., et al. POMC neurons expressing leptin receptors coordinate metabolic responses to fasting via suppression of leptin levels. Elife. 2018;7:e33710. doi: 10.7554/eLife.33710.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.33710</ArticleId><ArticleId IdType="pmc">PMC5866097</ArticleId><ArticleId IdType="pubmed">29528284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso J.A., Silveira M.A., Lima L.B., Furigo I.C., Zampieri T.T., Ramos-Lobo A.M., Buonfiglio D.C., Teixeira P.D., Frazao R., Donato J., Jr. Changes in Leptin Signaling by SOCS3 Modulate Fasting-Induced Hyperphagia and Weight Regain in Mice. Endocrinology. 2016;157:3901&#x2013;3914. doi: 10.1210/en.2016-1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2016-1038</ArticleId><ArticleId IdType="pubmed">27471877</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark C.M., Clark R.M., Hoyle J.A., Dickson T.C. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis. J. Neurochem. 2021;156:273&#x2013;289. doi: 10.1111/jnc.15125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15125</ArticleId><ArticleId IdType="pubmed">32654149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P., Sinniger J., El Oussini H., Scekic-Zahirovic J., Dieterle S., Dengler R., Meyer T., Zierz S., Kassubek J., Fischer W., et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139:1106&#x2013;1122. doi: 10.1093/brain/aww004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2018;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Ng C.S., Xiang P., Liu H., Zhang K., Mohamud Y., Luo H. Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2020;13:78. doi: 10.3389/fnmol.2020.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>